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ABSTRACT 
The study sought to establish the causes of non-adherence to ART medication regimens among 
people living with HIV. The research was conducted at Leratong Hospital in Johannesburg, 
Gauteng province, South Africa. 
The researcher selected a qualitative design in which 24 patients on ART and six healthcare 
providers in the field of HIV/AIDS, who fulfilled inclusion criteria of 18 and above years, were 
interviewed. Tape-recorded interviews as an instrument of data collection was used and patient-
participants were approached and requested to participate in one to one interview as they came to 
collect their medication. Health personnel were approached in their respective offices and asked 
to be interviewed. Thematic Content Analysis (TCA) was later used to generate themes. 
The results indicated that adherence levels among the patients were sub optimal (less than 95%). 
Social economic related factors such as poverty, stigma and fear of disclosure; and medication 
side effects profoundly influenced adherence. Patient-related factors such as lack of social 
support, preference of traditional medicines, feeling better, substance abuse; and one health 
system-related factor being staff shortages, had a little contribution to poor medication 
adherence. 
According to the study findings, the process of ART delivery at the clinic had no contribution to 
patients‟ non-compliance. In fact it was found to have been intended at providing extrinsic 
motivation to, and raising the levels of adherence among the patients. When the patients stated 
their views concerning the programme, the major problem lay with strict time rules and that gave 
birth to forgetfulness. Their suggestion directed not to the health centers, but sorely to the 
government and all stakeholders including the ARV drugs-manufacturers, was that ART be 
provided in the form of three to six months injection. 
The findings revealed that stigma exacerbates non-adherence, so, there is a need to intensify 
health education campaigns against stigma in communities, workplaces and households. 
The findings from this study showed a significant relationship between treatment adherence and 
gender, in which women are generally more compliant than men to ART, so it was 
recommended that men be given extra pre-ARV counseling and compliance checking. 
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OPSOMMING 
Die primêre doel van hierdie studie was om die redes te bepaal waarom MIV-pasiënte nie hulle 
antiretrovirale medikasie volgens die voorgeskrewe protokol en voorskrif gebruik nie. Die studie 
is gedoen by die Leratong Hospitaal in Johannesburg, Gauteng, Suid-Afrika 
Die navorser het „n kwalitatiewe ontwerp gebruik en het onderhoude gevoer met 24 pasiënte 
(wat antiretroviale medikasie gebruik) en ses gesondheidsorgwerkers. Beide die pasiënte en die 
gesondheidsorgwerkers het aan die voorafbepaalde kriteria vir die studie voldoen. 
Resultate toon dat pasiënte nie altyd by die voorskrifte vir die gebruik van hulle medikasie hou 
nie en dat dat daar „n sub-optimale (minder as 95%) voldoening aan medisyne-voorskrifte was. 
Redes vir hierdie swak voldoening aan voorskrifte kan grootliks toegeskryf word aan armoede, 
stigma en newe-effekte van die medikasie. Pasiënt-verwante redes, soos die gebrek aan sosiale 
ondersteuning en voorkeur vir tradisionele medisyne, het „n geringer bydrae gelewer tot hierdie 
swak voldoening aan medisyne-voorskrifte. 
Volgens die studie het het die proses, waarvolgens antiretoviale medikasie deur die klinieke 
voorsien word, nie „n beduidende rol gespeel in die geneigdheid van pasiënte om nie aan 
medisyne-voorskrifte te voldoen nie. Dit het egter geblyk dat die streng tydreëls wat deur die 
medisyne-protokolle voorgeskryf word, daartoe gelei het dat pasiënte dikwels vergeet het om 
hulle medikasie te neem. Pasiënte het sterk vertoë tot farmaseutiese ondernemings gerig om te 
probeer om medikasie te onwikkel wat op „n drie- tot ses maandelikse basis per  inspuiting 
toegedien kan word.. 
Die studie het ook aangetoon dat stigma die geneigdheid om nie te voldoen aan medisyne-
vereistes nie vererger en dat opvoedkundige programme om stigma te verminder, versnel sal 
moet word binne ondernemings. 
„n Laaste bevinding was dat daar „n positiewe verwantskap is tussen geslag en die geneigdheid 
om by medisyne-voorskrifte te hou. Vroulike pasiënte is baie meer getrou in die neem van hulle 
antiretovirale medikasie. 
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CHAPTER 1 
1.1 INTRODUCTION 
2011 marks the 30
th
 year of HIV/AIDS as part of human experience. The first reported HIV 
cases were identified in the early 1980s and since then, HIV/AIDS has continued to be one of the 
most destructive epidemics in the history of mankind. Since the beginning of the epidemic, AIDS 
has claimed more than 25 million lives and more than 60 million people have become infected 
with HIV. Still, each day, more than 7000 people are newly infected with the virus including 
1000 children (Report of the UN Secretary-General, 2011). 
UNAIDS (2010) estimated a global population of people living with HIV/AIDS as 33.3 million 
at the end of 2009. Of these, 15.9 million were women and 2.5 million were children. UNAIDS 
Global Epidemic updates reveal that AIDS is responsible for a decrease in life expectancy and 
increase in orphaning. In 2009 alone, AIDS killed an estimated 1.8 million people worldwide. 
There were an estimated 2.2 million people newly infected with the virus, when 16.6 million 
children became orphans due to AIDS (UNAIDS, 2010).  
Women are more vulnerable than men in some regions, and their deaths rob families of the 
primary caregivers (Ashford, 2006). Slightly more than half of all people living with HIV are 
women and girls. In Sub-Saharan Africa, more women than men are living with HIV, and 
younger women aged 15-24 years are as much as eight times more likely than men to be HIV 
positive (UNAIDS, 2010). 
In severely affected countries, HIV/AIDS causes slow economic growth and development by 
destroying human capital, discouraging investment and eroding productivity (UNAIDS, 2005). It 
also threatens health and social progress. Health care systems experience enormous demands as 
expenses are rising for the treatment of AIDS and AIDS-related opportunistic infections 
(Ashford, 2006).   
The business world has also been terribly affected by the HIV/AIDS epidemic. Employers are 
hard hit by the loss of workers, absenteeism, the rising costs of providing health-care benefits 
and the payment of death benefits. The pandemic has touched almost every facet of life and no 
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country has escaped the devastation of this truly global epidemic (Ashford, 2006 and Report of 
the UN Secretary-General, 2011). 
In the 2005 World Summit Outcome, the world leaders committed to measures to scale up a 
comprehensive response to achieve a multisectoral coverage of prevention, treatment, care and 
support with the intentions of getting close to the goal of universal access to treatment by 2015 
(United Nations: General Assembly, 2005). The UN Secretary-General admitted that their efforts 
have started bearing fruit. 
As at December 2010, more than six million people were estimated to be receiving antiretroviral 
therapy (ART) in low and middle-income countries (Report of the UN Secretary-General, 2011). 
In 2009 alone, 1.2 million people received ART for the first time, which was 30% increase of 
people receiving treatment in a single year. Expanding access to treatment has contributed to a 
19% decline in deaths among PLWHA between 2004 and 2009 (UNAIDS, 2010). 
New HIV infections are declining in many countries most affected by the pandemic. In 33 
countries, of which 22 are in Sub-Saharan Africa, HIV incidence has fallen by more than 25% 
between 2001 and 2009. Among young people in 15 of the most severely affected countries, HIV 
prevalence has fallen by more than 25% (UNAIDS 2010). 
Global coverage for antiretroviral prophylaxis to prevent the vertical transmission of HIV has 
exceeded 50%. As at December 2009, 15 countries had achieved the target set in the 2001 
Declaration of at least 80% coverage of antiretroviral among pregnant women living with HIV, 
and an additional seven countries in Sub-Saharan Africa reported coverage between 50% and 
80% (Report of the UN Secretary-General, 2011). As a result, 370 000 children were estimated 
to have contracted HIV during the perinatal and breastfeeding period in 2009, down from 500 
000 in 2001 (UNAIDS, 2010). 
However, with the year 2011 as a historic marker in the global response, the epidemic continues 
to outpace the response, underscoring the need to revolutionize efforts to prevent new infections 
(Report of the UN Secretary-General, 2011). The reports on HIV/AIDS indicate that HIV 
continues to weigh heavily on maternal and child mortality in some countries, and the world is 
still far from achieving the goal of protecting newborns from becoming infected (Report of the 
UN Secretary-General 2011, & UNAIDS 2010). 
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Having more than six million people receiving AIDS treatment marks the greatest public health 
achievement, but it represents only 35% of the population in need of HIV therapy (UNAIDS, 
2011).  The majority of people in need still lack access to the HIV treatment (Report of the UN 
Secretary-General, 2011). At the same time, non-adherence to HIV therapy (ART) still 
represents a significant challenge to the effective AIDS response in the world. 
ART is not a cure for HIV infection and AIDS. It is a therapy that prolongs life by inhibiting 
viral replication. By reducing the viral load and easing the burden on the immune system, 
infected individuals are able to survive much longer than in the absence of the therapy 
(Andersen, 2011). Non-adherence, therefore, increases the risk of viral mutation which can result 
in cross-resistance to other medications or transmission of multiresistant virus strains, and thus 
the risk of initial therapy failure in subsequently infected individuals (Glass et al. 2006). 
Non-adherence is perceived as the major problem and subsequently an obstacle to effective 
delivery of ART in Sub-Saharan Africa, especially in South Africa. This study was contacted 
with the intention of identifying reasons and causes of non-adherence in South Africa, 
particularly at Leratong Hospital in Johannesburg. 
 
1.2 BACKGROUND AND RATIONALE 
South Africa is experiencing a problem of high HIV prevalence which weighs heavily on the 
health care system. Estimates of prevalence come from surveys of specific groups (women 
attending antenatal clinics, STD clinic attendees, etc.) which are broadly representative of the 
general population (Whiteside et al. 2005). Determining the exact numbers of PLWHA in the 
country is barely possible, due to the fact that some people do not come forward for testing. For  
statistical adjustment that account for delays in reporting to the health department and missing 
risk factor information, estimated numbers are always used (CDC, 2009). This study, therefore, 
depends on the estimated HIV prevalence to reveal the current AIDS situation in South Africa. 
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1.2.1 The History of AIDS in South Africa 
The first two cases of AIDS were identified in South Africa in 1982. For the first eight years, the 
epidemic was primarily located among white male homosexuals (Whiteside & Sunter, 2000). 
Quickly the disease spread outside of the gay population and by 1991, the heterosexual 
transmission rate equaled the rate of new infections among men who had sex with men. By mid-
1990s, HIV rate had increased by 60% (Cichocki, 2011). At current, the country is characterized 
by high HIV prevalence rate, and low life expectancy. 
 
1.2.2 The current status of HIV/AIDS in South Africa 
South Africa is among the African countries which are most severely affected by the HIV/AIDS 
pandemic with the adult prevalence rate of 17.8% (UNICEF, 2010). It is 30 years since the first 
diagnoses of HIV, but the country‟s epidemiological situation is still marked by as large numbers 
as 5.6 million of PLWHA, (UNAIDS, 2010). Infection levels are highest among young females 
(Cichocki, 2011), and middle-aged men. Almost one in three women aged 20 to 29- and more 
than a quarter of men aged 30 to 34 are living with HIV in the country (White, 2010). 
As indicated by The South African Department of Health Study (2009), the HIV antenatal 
prevalence by province ranged from a high of 39.5% (KwaZulu-Natal) to a low of 16.9% 
(Western Cape). Mpumalanga, which is the second worst affected, Free State, Gauteng and 
North West recorded prevalence higher than the national average of 29.4%. Eastern Cape, 
Limpopo, Northern Cape and Western Cape recorded prevalence below the national average of 
29.4%. 
An estimated 263 900 people died of AIDS in South Africa in 2009. There were a total of 1.91 
million South African orphans due to the HIV/AIDS epidemic in the same year. The number of 
new HIV infections among adults aged 15 and more, was alarming estimated at 354 000, 
(Statistics South Africa, 2009). 
Heterosexual sex is recognized as the predominant mode of HIV transmission in the country, 
followed by mother-to-child transmission (MTCT). The factors driving the epidemic include 
migration, low risk perceptions, multiple concurrent partnerships, intergenerational sex, low 
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condom use, excessive use of alcohol, and low rates of male circumcision (USAID, 2011). 
Research on the burden of HIV among men who have sex with men (MSM) is currently being 
conducted in South Africa and is not a major source of HIV infection at present (Shisana et al. 
2008). 
The direct measurement of HIV incidence is extremely challenging, and there is presently no 
consensus in South Africa on the best method for measuring HIV incidence (Shisana et al. 2008 
in UNGASS, 2011). However, efforts are made on a continuous basis within the research 
community to reach consensus on the best tool and methodologies for measuring HIV incidence. 
The epidemic trends in the country are measured through two methodologies namely: the annual 
antenatal HIV prevalence survey and various population or household-based surveys which 
suggest that the country‟s epidemic is stabilizing (USAID, 2011). 
The economic impact of the AIDS epidemic is very severe, especially at household and 
community levels. Through deaths of young productive citizens, AIDS worsens dependency 
ratios and makes living standards deteriorate (Haacker, 2004:47). According to Ashford (2006), 
households experience the immediate impact of HIV/AIDS because families are the main 
caregivers for the sick and suffer AIDS-related financial hardships. During the long period of 
illness caused by AIDS, the loss of income and cost of caring for a dying family member can 
impoverish households (Ashford, 2006). The pandemic continues to be a serious threat to 
national economic security as it targets young, productive and innovative groups in South Africa. 
 
1.2.3 The HIV/AIDS epidemic in Gauteng 
Gauteng records one of the highest HIV prevalence rates of 29.8%, slightly above the national 
average of 29.4% (The South African Department of Health Study, 2009). Being the country‟s 
economic heartland, the province is characterized by the constant influx of migrants from other 
provinces; and neighbouring countries, who flock into Gauteng cities for employment 
opportunities, and this exacerbates the conditions of HIV/AIDS in the province. 
In Gauteng, HIV prevalence rate among women (aged 15-49) attending antenatal clinics was 
29.9% in 2008 alone. 46% of the population of children in need, under the age of 15 started ART 
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in the same year, while the estimated rate of HIV transmission from mother-to-child was 10.9% 
in 2009, (Yezingane Network: Provincial Profile, 2010). 
According to MRCR (2001 in Denies, 2007), the population most vulnerable to HIV infection 
are people residing in informal urban settlements, who are between the ages of 25 to 34. Females 
living under these conditions are more at risk of infection than their male counterparts. 
 
1.2.4 National Response to the AIDS epidemic 
South Africa has shown a high level of commitment to providing care and treatment for 
PLWHA, and prevention interventions for the reminder of the population (USAID: HIV/AIDS 
Health Profile-South Africa, 2011). The country has implemented a range of measures both at 
national and provincial levels to fight the epidemic and mitigate its impact. A national AIDS plan 
was published in 1994 – 1995 and a Partnership against AIDS launched in 1998. SANAC was 
also established in 1999 (UNESCO, 2004). SANAC was formed to strengthen the political 
leadership as well as to ensure inclusion of civil society in the overall response to HIV/AIDS. 
The objective behind the establishment of the council was mainly to advise government on 
HIV/AIDS and STI policy and strategy (South African Government Information, 2009). 
As indicated in HIV/AIDS Health Profile – South Africa (USAID, 2011), the government has 
since 2000 developed many policies and programmatic responses to ensure that there is a 
multisectoral response to HIV/AIDS. Campaigns came to exist in an effort to mitigate the 
HIV/AIDS epidemic in the country. These include education campaign aimed at imparting AIDS 
education to the nation, communication campaign, and HIV counseling and testing. 
For dissemination of information and proper understanding of the nature of the epidemic 
HIV/AIDS is, many HIV/AIDS communication programmes came to exist. These include 
communication programmes conducted by NGOs; programmes within the workplaces and 
institutions of learning such as schools and universities; provincial government programmes and 
interactive communications that include community-level campaigns such as door-to-door 
activities, not to mention four national-level HIV/AIDS communication programmes utilizing 
the media, (Shisana et al. 2009). 
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On World AIDS day, under the theme „I am responsible, we are responsible, South Africa is 
taking responsibility‟, new policies and measures to tackle HIV/AIDS, as well as a new HCT 
campaign to be taken in 2010, were announced. Included in the new policy on HIV/AIDS were: 
 Treatment for all HIV-positive infants under the age of one, regardless of their CD4 
count, 
 AIDS treatment to be initiated at a CD4 count of 350 or below for pregnant women and 
TB-HIV co-infected patients, 
 Mobilize testing for HIV through a mass national VCT campaign, and 
 HIV positive pregnant women with a CD4 count above 350 to start ARVs at 14 weeks as 
part of the PMTCT of HIV programme (UNGASS Country Progress Report, 2010). 
 
Antiretroviral therapy in South Africa 
The first project to routinely offer ART in the public sector and on a district wide basis in South 
Africa was started in Khayelisha in May 2001, (Coetzee et al. 2004 in Andrew et al. 2008) 
followed by a project in Gugulethu in September 2002, (Andrew et al. 2088).In April 2004, the 
national antiretroviral treatment (ART) programme was launched in the country (WHO, 2011), 
and it became the largest antiretroviral treatment programme in the world. This has been 
provided in around 500 public sector health facilities, mainly hospitals, and also some 
community health centers and clinics, (UNGASS Country Progress Report, 2010).  
By March 2006, there were 16 234 patients receiving ART (87% adults) across 43 sites, the 
majority being treated in primary-care settings; 67% in clinics and community health centres, 
and 13% in district hospitals (Andrew et al. 2008). Enrollment increased steadily, and by the end 
of 2009, around one million people were introduced and enrolled to ART (UNGASS Country 
Progress Report, 2010). 
South Africa currently provides ART for free to HIV-positive patients whose CD4 count is 350 
cells/mm3 (used to be 200), as per WHO recommendations. Pregnant women as well as TB-HIV 
co-infected patients were eligible to begin ART at the CD4 count of 350 cells/mm3 but now are 
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recommended to start HIV regardless of their CD4 count (Updated ART Treatment Guidelines: 
WHO and South Africa).  
As it seems, the HIV/AIDS prevention interventions and treatment are bearing fruit in the 
country. UNAIDS (2010) mentioned South Africa among 22 of 33 Sub-Saharan African 
countries in which the biggest epidemics (including HIV/AIDS) have stabilized or are showing 
signs of decline. According to UNAIDS, the country has achieved almost 90% coverage of 
treatment to prevent mother-to-child transmission of HIV, and the result is that transmission to 
infants has been drastically reduced. 
Researchers have discovered encouraging signs that change in prevalence and incidence are now 
occurring. HIV prevalence at national level has decreased among children aged 2-14, from 5.6% 
in 2002 to 2.5% in 2008, and HIV prevalence has decreased among youth aged 15-24 from 
10.3% in 2005 to 8.6% in 2008. However, HIV prevalence remains disproportionately high for 
females overall in comparison to males, more than twice as high as that of males in the age 
groups 20-24, and 25-29, (Shisana et al. 2008). 
 
1.3 RESEARCH PROBLEM 
The current situation shows that efforts are made to mitigate the disease and help those living 
with HIV to live longer by way of providing free ART treatment. However, one can still observe 
that medication adherence is still a problem among PLWHA, even after being told several times 
about the importance of ART to their lives. 
In some cases, the conditions of patients cannot be described in any form other than „not 
extrinsically or intrinsically motivated to be adherent‟ if not „fearing to take their ART 
medication ‟. But the bottom line is, some patients either take their medication irregularly, which 
is against their health providers‟ instructions, stop taking it at all or miss the dates scheduled for 
appointments. In any case, the reasons behind non-adherence may be complex. Circumstances 
beyond the patients control may be responsible for high levels of non-adherence in the country. 
HIV/AIDS accounts for at least 43% of deaths in the country (Statistic South Africa, 2009), and 
this could obviously be one of the consequences of patients defaulting from ART treatment. The 
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causes differ from one area to another depending on the demographic characteristics of the 
patients, level of competence, dedication and commitment among the health personnel and 
economic situations in the community. But whatever the case may be, poor adherence and 
defaulting from treatment are the main challenges faced by ART programme in South Africa. 
 
1.4 RESEARCH QUESTION 
What are the reasons behind non-adherence to antiretroviral therapy (ART) among people who 
are living with HIV/AIDS? 
 
1.5 SIGNIFICANCE OF THE STUDY 
This study therefore, sought out to investigate and finally reveal the barriers, reasons and causes 
of non-adherence of PLWHA to antiretroviral therapy at Leratong Hospital. Key findings from 
this study will provide the Department of Health in Gauteng province, donors, policy makers and 
all other stakeholders with comprehensive information that will enable them to devise other 
strategies and appropriate mechanisms to raise the levels of ART adherence among those on 
ART treatment in the country.  
Contributing to the evidence base for ART adherence should assist the Department to come up 
with the plan of improving uptake of drugs, ensure effectiveness of ART treatment and try to 
prevent the development of drug resistance. In the final analysis, the study will contribute to 
reduce early AIDS related deaths which bring about loss of skilled labour in the country, thus; 
threatening economic security. 
 
1.6 AIM AND OBJECTIVES OF THE RESEARCH STUDY 
  1.6.1 Aim  
To establish the main causes of non-adherence to ART medication at Leratong hospital in order 
to make recommendations to address ART non-adherence. 
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  1.6.2 Objectives 
(a) To establish factors contributing to non-adherence, 
(b) To establish the process of ART delivery to the patients, 
(c) To obtain health providers and patients view of the ART programme, and 
(d) To make recommendations for effective delivery of the programme. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 INTRODUCTION 
The treatment of HIV/AIDS has evolved in the last 30 years since the beginning of the epidemic 
from no treatment to treatment with a single drug (AZT) to dual-drug therapy and, now to 
HAART, a treatment with at least three active antiretroviral medications (ARVs), either two 
NRTI‟s with PI or two NRTI‟s with a NNRTI (NYU Medical Center, 2009). Still, it is currently 
impossible to eliminate HIV/AIDS pandemic using available therapies. In the absence of cure, 
ART remains the only available option that offers the possibility of dramatically reducing 
HIV/AIDS-related morbidity and mortality, while improving the status of PLWHA (Wekesa, 
2007).  
As Andersen (2011) indicates, the purpose of ART is immune reconstitution, a process in which 
the therapy inhibits the viral load or suppresses the disease, thus, allowing the immune system to 
recover and regain its function. Immune reconstitution is associated with a replenishment of the 
destroyed CD4 or T cells and improvement in their function to fight the intruders and reduce the 
risk of HIV-associated diseases, thus, delaying progression to full blown AIDS (Andersen, 2011; 
NYU Medical Center, 2009). 
Ever since the introduction of ART in the treatment and management of the HIV/AIDS 
epidemic, HIV infection has entered the stage of chronic disease management (Tracy et al. 
2006). However, success of the therapy is dictated by proper clinical management and most 
importantly, effective involvement of patients as active agents in their own care and treatment 
(Webber, 2004). ART requires that patients maintain nearly perfect (≥ 95%) adherence to the 
prescribed regimens (Mayer & Stone, 2001). However, non-adherence to ART medication 
regimens marks the major public health problem in the successful management of HIV/AIDS. 
Medication non-adherence is most simply defined as the number of doses not taken or taken 
incorrectly that jeopardizes the patients‟ therapeutic income. Non-adherence can take a variety of 
forms, including not having a prescription filled, taking an incorrect dose, taking a medication at 
the wrong time, forgetting to take doses, or stopping therapy at all, (Bethesda, 1997). 
Stellenbosch University http://scholar.sun.ac.za
 12 
 
At an individual level, failure to realize adequate levels of adherence is reflected in the effect of 
treatment on virologic, immunologic and clinical outcomes (Veenstra & Whiteside, 2010). Poor 
adherence to HAART leads to the exposure of the virus to inadequate concentrations of ARV 
medications. This in turn leads to ongoing viral replication, development of resistance to ARV 
medications and increased vertical transmission (Igwegbe et al. 2010), thereby quickening the 
virus progression to full blown AIDS stage. In harmony with the aim of the study, this part 
focuses its attention mainly on ART adherence and the reasons and barriers of adherence after 
initiation of ART.  
 
2.2 ART ADHERENCE MEASUREMENT 
The measurement of ART adherence of patients has been a major challenge because of the 
subjective and private nature of pill taking behaviour in ambulatory patients. This challenge is 
caused by the fact that adherence is not only affected by patients‟ behaviour alone, but also by 
health system, socioeconomic, disease-related and drug-related factors (Steel et al. 2007). 
Although no gold standard exists for the precise measurement of adherence to ART in clinical 
care, levels of adherence can be estimated by a number of approaches (AIDSTAR-One, 2010), 
which are direct and indirect.  
Direct and objective measures include: DOT in which the health care workers directly administer 
medicines to patients and observe them taking the medicine (Steel et al.);TDM, which involves 
measuring drug levels in the blood; biological markers where monitoring  viral load is used as an 
indicator of effectiveness of treatment and, thereby, of medication intake, (AIDSTAR-One, 
2010) and MEMS. According to Poppa et al. 2004; Population Council et al. 2004 (in Wekesa, 
2007) MEMS is a method that uses an electronic device that is fitted on the lid of the medication 
bottle. This device records the time and date of opening and closing the lid, which is assumed to 
coincide with intake of the medication. MEMS is considered to be the current state of the ART 
method of evaluating adherence, largely because adherence is most predictive of clinical 
outcome when measured with this methodology (Bangsberg et al. 2001; Arnsten et al. in 2001 in 
Steel et al, 2007). 
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As cited by Steel et al. (2007), indirect measures include: pharmacy refill records where patients 
collecting their medications regularly on due dates are assumed to be adherent; self-report 
(including CASI) –  the most commonly used method, especially in resource-poor settings, in 
which the patients are asked to report on their own adherence through a series of questions 
(Wekesa, 2007); pill count, in which health care providers, pharmacists, and providers of DOT 
count the pills and the number of remaining pills is assessed to measure adherence to treatment 
over a specific period of time based on the refill date and daily dosage , (AIDSTAR-One, 2010); 
visual analogue scale, where the patient is asked to place a mark somewhere along the line from 
0 to 10 that best describes their adherence to the prescribed ARVs. The last measure is PIT, 
which involves inviting patients to distinguish the pills in their regimen from a display of ARVs, 
including two „twin pills‟ which are similar but not identical (Brown et al. 2004 in Steel et al. 
2007). This is done to provide further evidence that the patient has a thorough understanding of 
how to take prescribed medicines (Steel et al). 
 
2.3 THE MAGNITUDE OF NON-ADHERENCE 
In all chronic diseases, non-adherence is a global problem. According to WHO (2003), 
adherence to long-term therapies in the general population is around 50% in developed countries,  
and is much lower in developing counties. In the treatment of HIV/AIDS, adherence to ARV 
agents varies between 37% to 83%, depending on the drug under study, (Stein et al. 2000; in 
WHO, 2003).  
Different studies which were conducted in South Africa resulted in different levels of adherence. 
In the study that was conducted in Gauteng Pretoria, which evaluated 180 patients enrolled on 
ART between July 2004 and August 2005, only 52.2% of the participants reported taking at least 
or over 95% of their prescribed doses (Malangu, 2008). In another study that took place in Cape 
Town, in which 289 patients accessing treatment were evaluated, 63% of patients maintained 
adherence of 90% (Steel et al. 2007). It is estimated that 50% of prescriptions filled are not taken 
correctly .Generally, more that  10% of patients report missing one or more medication doses on 
any given day, and more than 33% reported missing doses in the space of two to four weeks 
(Chesney 2000; in Steel et al. 2007). 
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2.4 THE REASONS FOR NON-ADHERENCE 
As revealed in studies conducted in both resource poor-settings and resource rich countries, it is 
quite clear that non-adherence to the strict ARV regimens is common for a variety of reasons 
which include: 
 
2.4.1 Financial constraints. 
Studies looking at adherence in resource limited-settings draw out a number of additional and 
generally more prevalent concerns highlighting economic burdens borne by patients and their 
families in accessing AIDS treatment (Veenstra et al. 2010). These burdens include the cost of 
medication, the cost of user fees, an inability to care for other members of the family during 
medical visits, and absenteeism from work (Castro, 2005 in Wanjohi, 2009; Veenstra et al. 
2010). Even in the context of free drugs, the cost of transportation to obtain ARVs is one of the 
reasons given for non-adherence. Inability of patients to afford medication and the tendency to 
sell own drugs because the money is needed for something else also contribute to non-adherence, 
(Daniel, 2004; Yu in Uzochukwu et al. 2009). 
 
2.4.2 Medication side effects 
Investigators have reported finding an association between the occurrence of side effects during 
treatment with ART and decreased adherence to ART (Hechet 1998, & Stone et al. 1998 in 
Mayer & Stone 2001). Different drugs have different side effects some of which cause stomach 
irritation or nausea and others cause cramps and diarrhea. Some drugs are associated with 
sleeping disturbance, loss of concentration, nightmares and depression (Andersen, 2011). 
Different drugs have different toxicity profiles (Andersen, 2011). As revealed by Fomundam, 
(2010), the use of PIs is likely to make the level of glucose rise, resulting in hyperglycemia. This 
subjects the victim to severe headache, fatigue and the patient might end up having vaginal and 
skin infections, nerve damage causing painful cold or insensitive feet, loss of hair on the lower 
extremities and many effects. PIs can also cause increases in the blood lipids (fats) and may 
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precipitate diabetes.  Certain drugs such as AZT affect blood cells and may lead to a fall in the 
red-blood cells (anaemia) or white blood cells (leukopenia). Efavirenz causes depression, 
nightmares and psychosis (Andersen, 2011). 
The researchers show that other anti-HIV medications have deadly side effects, (Andersen, 2011; 
Fomundam, 2010). Long term use of NRTI‟s can lead to fatty changes of the liver and the life-
threatening disturbance in metabolism called lactic acidosis; and NRTI, NNRTI and TI proved to 
be the cause of hepatotoxicity, which is „a general term for liver damage‟. Fomundam goes 
further to indicate that, this toxicity can cause liver failure and death. Some non-preventable 
diseases such as lipodystrophy, (a condition characterized by changes in body-fat distribution), 
are a result of using anti-HIV medications such as (Zerit) NRTI and PIs. NRTIs, especially Zerit 
(stavudine), Videx (didanosine), and Retrovir (zidovudine), are associated with lactic acidosis 
and hepatic steatosis. NNRTIs, especially Viramune (nevirapine), are associated with hepatitis 
and hepatic necrosis, (AIDSinfo, 2005). Indinavir forms crystals in the kidney and urine and if 
the patient does not drink enough water, it is likely to lead to kidney damage or painful kidney 
stones (Andersen, 2011). 
Researchers have discovered that deformation can be one of severe anti-HIV medication toxic 
effects (AIDSinfo, 2005; Fomundam, 2010). PIs increase a person‟s risk of developing 
osteopenia and osteoporosis (AIDSinfo, 2005). These are bone diseases characterized by the 
deterioration of bone tissue. People with these diseases are at a high risk of bone fractures, as the 
diseases cause the bones to become more fragile. The fracture may cause neck or back pain, bone 
pain or tenderness, loss of height and stooped posture, (Fomundam, 2010). If the bone becomes 
fragile, it is easy for the bones of a victim to be unable to carry him, resulting in deformation. 
The patients with side effects might logically be expected to reject medication (Blackwell, 1976) 
because some anti-HIV medications have excruciatingly painful side effects and can cause 
severe physical discomfort. 
Even though ART improves survival of those infected with HIV, its use can be associated with 
adverse changes in body composition (Kim & Rutstein, 2010). Changes in the distribution of 
body fat that are associated with ART can be disturbing to patients. The loss of facial fat, 
especially around the cheek-bones make people look emaciated and feel that their HIV status is 
visible to everybody. Other changes are increased fat between the shoulder blades, on the 
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stomach, buttocks and breasts, (Andersen, 2011). In the study that was carried out to evaluate the 
metabolic and body composition changes among northern Indian patients receiving combination 
ART, in which 68 adult patients were studied in the period of six months after which the body 
mass index, waist circumference, total body fat and lean body mass had increased significantly, 
(Gupta et al. 2010). Changes in body compositions are the most disturbing consequences of 
taking ART on the part of some patients (Andersen, 2011).  
The findings that experience of side effects is the commonest reason for non-adherence are 
plausible because, in the early period of treatment in particular, side effects occur relatively 
frequently and they have potential to substantially reduce the quality of life (Uzochukwu et al. 
2009). 
 
2.5 BARRIERS TO ADHERENCE TO ART 
Despite the critical need for strict adherence to the medication regimens, barriers to ART 
adherence have increasingly become the major problems and center of attention in recent 
research studies conducted both in high-income and resource-limited countries. Factors affecting 
medication adherence are generally the same, but the difference is brought about by literacy 
levels, demographic characteristics of patients and economic situation from one place to another. 
 
2.5.1 Patient related barriers 
Barriers to treatment adherence include factors related to individuals such as forgetting, busy 
time schedules, excessive alcohol intake, poor disease and treatment literacy (Manda, 2011), low 
level of academic education which is associated with low levels of understanding of medical 
instructions (Kalichman et al. 2000 in Kagee, 2008). Other barriers to adherence are poor self-
confidence, beliefs about the efficacy of the treatment and alternate therapies. There are eight 
other reported barriers falling under category of beliefs. These include side effects (real or 
anticipated), complicated regimens, taste, size, and frequency of dosing; having doubts about 
combination ART efficacy, feeling fine or healthy, decreased quality of life while taking 
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medications; feeling too sick and being uncertain about long term effects of HIV treatment 
(Mbori-Ngacha ,2004; Weller, 2004).  
Depression and other psychiatric illnesses have been shown to be related to poor adherence to 
ART regimens as well as having a significant impact on the overall quality of life for PLWHA in 
both high-income and resource-limited countries (Amberbir et al. 2008; Byakika-Tusiime et al. 
2009; Dalessandro et al. 2007; Starace et al. 2002 in AIDSTAR-One, 2010).  Among general 
medical patients, researchers discovered that depressed patients are three times less likely than 
non-depressed patients to adhere to medical treatment (DiMatteo et al. 2000 in Kagee, 2008). 
Furthermore, depressed persons may be too unmotivated or fatigued to attend clinical 
appointments and may be overwhelmed by helplessness and hopelessness to the extent that they 
may question the purpose of optimal adherence. A diminished ability to think and concentrate, 
which is symptomatic of depressive episode, may negatively influence their memory to take their 
medication on time (Kagee, 2008). 
Other factors associated with poor adherence include barriers such as wanting to be free of 
medication or preferring a natural approach due to treatment fatigue; feeling that treatment is a 
reminder of HIV positive status, wanting to be in control and lack of self-worth (Castro, 2005; 
Nikayemba et al. 2005; Mills et al. 2006 in Wanjohi, 2009). Unemployment, unstable living 
conditions, and lack of effective social support networks are factors reported to have a significant 
effect on adherence (AIDSTAR-One, 2010). Social support for adherence is obtained from 
different sources such as partners, children, friends and relatives (Wekesa, 2007). Scholars have 
identified that difficult family circumstances contributed by high migration rates, teenage 
pregnancy, overcrowded living conditions, family violence, substance abuse are conditions that 
may lead to poor social support in South Africa, resulting in compromised adherence rates 
(Kagee, 2008). 
 
2.5.2 Health care team and system-related factors 
Health system barriers such as inaccessibility of ART in health centers were reported to have had 
a significant effect on adherence to HIV treatment. In researches conducted in resource-poor 
settings, the frequent ARV drug stock-outs at several facilities, irregular and untimely supply of 
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medication to patients, the inability to purchase more due to financial constraints were the major 
concerns compromising the rates of adherence to ART (AIDSTAR-One, 2010; Makhtar-Yola et 
al. 2006; Uzochukwu et al. 2009). Poor adherence to treatment was also the result of the lack of 
access to the health facility to pick up medications due to distance to the facility, constrained 
facility hours, and waiting times (Hardon et al. 2007; Kip, Ehlers, and van der Wal 2008; Weiser 
et al. 2003 in AIDSTAR-One, 2010). 
Other barriers in this category are brought about by healthcare workers with a poor 
understanding of the dynamics of adherence, thus: achieving adherence is an interactive process, 
and that, achieving adherence is not a one-time-only event, resulting in failure to engage the 
patients as active agents in their therapy; overworked staff with insufficient time or energy to 
engage the patient effectively; poor linkages between the healthcare team and PLWHA 
community support groups; healthcare workers with a poor understanding of the client (Weller, 
2004) and the therapy. When initiating new medications, physicians often fail to communicate 
critical elements of medication use, and this contributes to misunderstandings about medication 
directions or necessity and, in turn, leads to patient failure to take medication as required 
(Derjung, 2006).  
Another barrier of paramount importance in the delivery of the therapy and its adherence is 
patient-healthcare provider relationship. A poor healthcare provider-patient relationship is highly 
associated with non-adherence as it blocks interaction between the two parties being the patient 
and health workers, and gives birth to negative attitudes on the part of the patient (Adherence to 
Medical Advice, 2011). Researchers found that patients are more compliant if their physician is 
warm, caring, friendly and interested, and, a successful healthcare provider-relationship requires 
a mutual respect, honesty and openness, which most healthcare practitioners lack. Such a 
relationship allows patients to benefit maximally from the healthcare knowledge and skill, and 
the health worker will be more likely to respond appropriately to the patient‟s needs and 
expectations. In the absence of this relationship, patients do not take medication as prescribed 
(Costello).   
Research has demonstrated that adherence can be facilitated when a patient-provider relationship 
incorporates trust, good communication, adequate education about medication, and an overall 
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perception of caring, including a culturally and linguistically appropriate approach to the 
relationship, (Peralta et al. 2007). 
 
2.5.3 Fear of stigma and disclosure 
High levels of stigma within the communities due to lack of education and awareness of HIV 
often leads to reduced levels of adherence to HIV treatment (AIDSTAR-One, 2010). 
Stigmatizing attitudes and actions include discrimination, avoidance, ridicule, harassment and 
even forceful removal of PLWHA from their homes (Rao et al. 2007; UNAIDS, 2005 in 
Wekesa, 2007).  If PLWHA are seen by member of their social constellation such as neighbours, 
family members, or friends, to be taking ART, this is likely to convey a signal that they are HIV 
positive (Kagee, 2008). As a result, patients are likely to have frequent treatment interruptions 
since their tablets must be hidden and therefore not taken in the presence of others for fear of 
being stigmatized (Uzochukwu et al. 2009). This in the end gives birth to attempts to change 
dosing schedules or suppress observable side effects of treatment (kagee, 2008). According to 
Klitzman et al. (2004 in Kagee), even disclosure to others may result in negative attitudes that 
may inhibit adherence to medication regimens. 
 
2.5.4 Daily life schedules 
Studies show that adherence is affected by disruptions in daily life schedules which include 
travelling out of town for work or to visit family, long hours of absence from home, and not 
bringing medication (Watt et al. 2009 in Herstad, 2010), trouble incorporating work and family 
responsibilities with ART, and being too busy or distracted to comply properly (Manda, 2011). 
Other include difficulty of balancing the numerous dietary requirements associated with 
HAART; and having no time to refill prescriptions or other pharmacy related problems and 
difficulties with a particular dose, the middle-of-day or early-morning dose (Castro, 2005; Mills 
et al. 2006 in Wanjohi, 2009). 
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2.6 SUMMARY 
The factors intruding upon the patients‟ decision to adhere to ART medication regimens were 
derived in many adherence quantitative studies and presented in the same sequence used by 
WHO. Researchers classified factors which influence adherence to treatment into four 
categories: therapy related factors which include side effects, complexity of regimen, food 
requirements, frequent changes in treatment and duration of treatment; healthcare team and 
system related factors being healthcare provider-patient relationship, clinical setting and service 
delivery factors such as counseling and appointment schedules; condition related factors which 
are illness related demands,  and co-morbidities such as depression; and patient related factors 
which include psychological stress, anxiety about possible adverse effects, low motivation, lack 
of self-perceived need for treatment, poor literacy, beliefs about the efficacy of the treatment and 
alternate therapies, and medication fatigue, to mention but a few. The above mentioned non-
adherence factors were further investigated in this study to examine the extent to which they 
were applicable to the study population (Weller, 2004; WHO, 2003). 
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CHAPTER 3: RESEARCH DESIGN AND METHODS 
3.1 INTRODUCTION 
This chapter sets out to explain methodology used in the entire study. It looks at the study 
setting; study design; research participants and sampling; data collection and data analysis 
technique; and ethical considerations. The above mentioned phases were considered in 
chronological order. 
 
3.2 THE STUDY SETTING 
Gauteng is situated in the northern-eastern part of the country, and it is landlocked by Limpopo 
in the north, Mpumalanga in the east, Free State in the south and North West in the west 
(Bradshaw et al. 2000). It comprises mainly of the three urban areas of Pretoria, Vereeniging and 
Johannesburg. Although the smallest province in surface area, it contributes 33% to the national 
economy and a phenomenal 10% to the GDP of the entire African continent (Bradshaw et al. 
2000; South Africa.info, 2011). This contributes to influx of migrants who flock into the city of 
Johannesburg in search of job opportunities.  Johannesburg is the capital, and the biggest city, 
not only in South Africa but in Africa as a whole. It is a single municipality that covers over 
1645 square kilometers (Africa.info, 2011). Except for HIV/AIDS, homicide and road accidents 
feature highly for men and women as the leading causes of death in the province (Bradshaw et 
al. 2000). 
The study was conducted at Leratong, a regional hospital based in the Western part of Gauteng 
Province in Johannesburg. The hospital has a bed capacity of 900, and it serves as a catchment 
area of 1.5 million people. The hospital key health problems are HIV/AIDS, Tuberculosis and 
Trauma (South Africa.info, 2011; Leratong hospital trauma unit gets major upgrade, 2011). It is 
a huge hospital with different sections. HIV/AIDS section named Kgothalang Clinic commenced 
its AIDS-related day-to-day operations in 2004. From 2004 to when the study was conducted in 
November 2011, the clinic ART initiations added up to 10347. Adult women constituted 55% of 
this number, men 36% and the remaining were children. (October Report, 2011). 
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3.3 RESEARCH DESIGN 
The researcher selected qualitative design in which patients on ART and healthcare providers in 
the field of HIV/AIDS were interviewed. Thomson (2007) shows that qualitative research 
method is primarily concerned with „why something happens‟.  This is an interpretive research 
approach, in which the researcher continually attempts to understand the data from the 
participants‟ subjective perspective hence it relies on multiple types of subjective data.  
Important task for the qualitative researcher is to understand the insiders‟ views, then take the 
role of objective outsider and relate the interpretive-subjective data to the research purpose and 
research question (Christensen, Johnson & Turner, 2011).  
Since the purpose of the study was to research the reasons why some PLWHA adhere poorly to 
the treatment or stop taking their medication completely, qualitative approach was the best 
method of data collection to allow the researcher to explore a variety of issues behind ART non-
adherence. 
 
3.4 PARTICIPANTS AND SAMPLING 
The sample size was 30 participants who were randomly selected to participate in the study. In 
this sample size of 30 participants, 24 were patients and six were healthcare providers. The 
patient-participants, both males and females were approached and requested to be interviewed 
when they already came to collect their medication at the hospital or had doctor‟s appointments. 
The timing of the interview was during the usual clinic visit process and the researcher adapted 
timing and participation to the convenience of the patient-participants to ensure that the process 
was not disrupted. 
Only the participants who consented to take part in the study were immediately interviewed. The 
participants were only included if they fulfilled the inclusion criteria, that is, the patients who 
had been on the treatment for at least six months, 18 and more years old and patients whose 
physical and psychological conditions had not deteriorated. The six months and above stipulation 
was necessitated by both the physical and psychological conditions of the patients who have just 
been initiated to the therapy. In most cases they are still experiencing physical discomfort as a 
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result of medication side effects; others are still in the process of immune reconstitution, as such 
physically weak; when other patients are still adjusting to the fact of lifelong treatment, as a 
result, having a very compromised immune system due to psychological stress they are subjected 
to by knowledge that their lives are dependent on HIV drugs. In the South African constitution, 
18 years of age marks the beginning of adulthood and only adults can, on their own, consent to 
participate in the study, hence the patients below 18 years of age could not satisfy inclusion 
criteria.  
Healthcare providers‟ inclusion criterion was that they had to have been in service for at least 12 
months. The researcher found a minimum of one-year experience necessary, given the purpose 
and objectives of the study, which required in-depth interviewing. As a consequence, the 
respondents‟ answers had to be more from experience than opinion. 
Gender balance of a 1:1 ratio was unattainable. The reason for this imbalance was the lower 
number of male patients and their reluctance to be interviewed. Most male patients who were 
approached and asked to participate did not consent. Some men who were willing to take part did 
not fulfill the inclusion criteria. In the end, 15 female and nine male patients participated in the 
study. Due to fear of participants experiencing trauma incited by the interview, an experienced 
counselor was readily available in the nearby room to help the interviewees. 
Healthcare personnel comprised of counselors, social workers, doctors, pharmacists and nurses.  
The doctors and pharmacists had, for the duration of the interviews, tied schedules that they 
obviously could not squeeze an interview in between the pressures that they had. In the 
remaining categories the researcher was able to interview at least one health practitioner. With 
regard to healthcare providers, gender did not count as their interview focused more on the 
delivery of the ART programme. Experience was the most important in this study. The 
personnel‟s service time ranged from two to seven years. 
 
3.5 DATA COLLECTION AND ANALYSIS TECHNIQUE 
Tape recorded semi-structured interview was used as an instrument of data collection. Semi-
structured interviews are conducted with a fairly open framework which allows for focused, 
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conversational, two-way communication (Case, 1990), resulting in greater exploration of the 
issue. Data collection was done through a face to face interview with one participant at the time. 
Interview schedule consisted mainly of open-ended and closed questions. Probes and rephrasing 
were used quite often during the interview sessions for patient-participants to understand the 
questions thoroughly and provide detailed information. The interviews lasted 12 to 30 minutes 
each, and interviews with the patients were conducted in the closed room at the clinic to make 
them feel secure and not exposed, while interviews with health practitioners took place in their 
respective offices. 
Thematic Content Analysis (TCA) was later used to generate themes. TCA is analysis that is 
based on identifying themes in qualitative material, often by means of coding scheme. It is a 
descriptive presentation of qualitative data, and this qualitative data may take the form interview 
transcripts collected from research participants or other identified texts that reflect experientially 
on the topic of study (Anderson, 2007). Distinct thematic units emerging from the interviews 
were identified, similar and dissimilar units grouped (Anderson), and thematic concerns which 
emanated from the interview were translated and presented into English. 
 
3.6 ETHICAL CONSIDERATIONS 
Permission was sought from Gauteng Department of Health and Social Development (GDHSD). 
Informed consent was sought from all the study participants who were also guaranteed of 
confidentiality, anonymity and privacy. All interviews were conducted in a private setting where 
participants could not feel exposed, and only the researcher interviewed the respondents in one to 
one interview. The respondents were also assured that no information would be linked to any 
individual person who participated in the research study. Health workers participating in this 
research had to sign a confidentiality agreement to protect patient-participants from being 
exposed either directly or indirectly. All patient-participants were given monetary incentives. 
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CHAPTER 4: RESULTS AND DISCUSSION 
4.1 INTRODUCTION 
This chapter sets out to present the qualitative findings of the study, with the patient-participants 
results presented first and separately from health personnel‟s and then discussion of findings. 
Both patients‟ experiences with the therapy, which could be the causes or barrier to medication 
adherence for some patients; and the manner in which the patient responded to each challenge, 
which determined the magnitude of non-adherence; are presented in charts, graphs and tables. 
The presentation of the findings of this study is mainly descriptive. 
 
4.2 PATIENT-PARTICIPANTS 
A total of 24 adult participants consented to participate in the interviews. Of this, 62.5% were 
females, when males constituted only 37.5%.  The number of men attending the clinic was 
smaller than that of women; and they were unwilling to take part as interviewees in the study, 
which revealed the fact that women are generally more open than men to talk about their HIV 
status. Patient-participants‟ age experience with the therapy ranged from six month to 11 years as 
demonstrated in figure 4.1 below. 
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Figure 4.1  
 
 
Figure 4.1 Distribution of respondents according to age experience with ART 
Figure 1 illustrates that 11 participants‟ (45.8%) age experience, which was the lowest but 
constituting the majority, ranged from six to 23 months, and the highest age experience with 
ART was 11 years, but there was only one patient (4.2%) who had been on ART for that long. 
 
4.2.1 Problems experienced with medications 
a) Medication side effects 
When the patients were asked to provide a detailed account on how their bodies responded to 
medication shortly after ART initiation, 83% reported experiencing side effects some of which 
were severe. The table below depicts both side effects and the numbers of patients to whom 
medication caused physical discomfort. 
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Table 1 Depicting side effects experienced by respondents 
GENERAL PATIENTS 
EXPERICES WITH ART 
GENDER 
DIFFERENCES 
TOTAL # OF 
PATIENTS 
PERCENTAGE 
Minor side effects included: 
Nausea, sweating, dizziness, 
fatigue, 
Males: 5 
Females: 5 
 
10 
 
41.7% 
Severe side effects included: 
Body sores, big stomach, big 
breasts, rush, red lips, diarrhea, 
painful leg bones, mental 
disturbance. 
Males: 2 
Females: 8 
 
 
10 
 
 
41.7% 
No side effects Males: 2 
Females: 2 
4 
 
 16.7% 
 
Table 1 
Table 1 depicts side effects experienced by the study participants. One out of 10 patients 
constituting 41.7% experienced one, two or three of severe side effects mentioned in the table 
above, and the same thing applied with minor side effects. Patients who experienced both minor 
and severe side effects were counted under severe side effects. Although 83% of the patient-
respondents reported experiencing side effects, only five (21%) defaulted from ARV treatment. 
In these five default cases, only two came into being as a result of medication side effects. One 
default case was due to severe sickness, but this sickness was caused by medication. 8.3% of 
patients nearly stopped the treatment as a result of severe side effects but 58% did not get even 
close to defaulting from their ARVs.  
The study population consisted of more women than men. Among the defaulters, four were men 
and one a female. No women reported getting tempted to stop their medication while two close-
to-quitting medication cases emanated from male respondents. 
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b) Medication time-related requirements 
When the patients were asked as to how much of a challenge was presented by keeping dates 
scheduled for appointment and sticking to specified times for taking pills, they provided many 
various responses demonstrated in the bar chart below. 
Figure 4.2  
 
Figure 4.2 Patients’ adherence to time 
Only 67% never missed a date scheduled for appointments, 33% missed a date once, twice or 
thrice. The reasons mentioned by the participants were different. Three patients reported 
appointment time coming when they had defaulted from the treatment, one had fallen sick, two 
mentioned work commitments denying them time to report at the clinic, and two said they 
experienced transport problems. 
As for dosing times, only 42% of the respondents indicated to have maintained the required 
adherence levels in that they had never skipped a dose. 58% reported to have skipped several 
doses since their initiation to the therapy; one time, two or three times in a space of a month, but 
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most said they did not allow the whole day to go without them taking their pills; and at times 
they went through a month-period without a dose being missed.  
 
4.2.2 Reason(s) for missing dose(s) of ARV treatment  
The bar chart below shows the reasons for skipping doses and the number of times each was 
mentioned in the qualitative research interviews. 
 
Figure 4.3  
 
Figure 4.3 Frequency of reasons for missing doses of ART 
In some cases, one patient mentioned more than one reason. The most frequently mentioned 
reasons were forgetfulness and poverty. Forgetfulness was mentioned by 71% of patients who 
failed to adhere to specified times, as one of the reasons and poverty by 64%. In 64%, two 
respondents reported failing to keep appointment dates due to lack of transport money. Seven 
patients reported that they frequently experienced food shortages and could not take medication 
on empty stomach. With regard to stigma/disclosure, two respondents mentioned staying with a 
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lover for whom the HIV status was concealed, and that affecting adherence as the patients had to 
take the tablets only in the absence of the partner. Five patients reported having fear of taking 
medication in public view, that is, in taxis, at work or at any place where the patients felt 
exposed to the sight of people.  
Two of the five patients reported that they could not take medication at all should the time for 
medication come when they were in public view, and three said that they found ways to take the 
pills. They might take them a few minutes late but they made sure that the pills were taken 
within the timeframe.  
 
4.2.3 Adherence tools used as reminders by patients  
The patients who reported having not skipped a dose disclosed different ways in which they were 
reminded to take their medication. Figure 4.4 below presents adherence reminders mentioned by 
the respondents. 
Figure 4.4  
 
Figure 4.4 Presenting adherence tools used by the patients 
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Four respondents said that they set phone alarm to remind them when the time for medication 
had come. Two of them mentioned family members, especially their children; two indicated their 
bodies as automatic alarms for them to take their pills. They stated that they felt when they 
should take medication; one mentioned TV programs as the reminder and one patient did not use 
anything as a reminder, the patient just remembered when that time for HIV drugs had come. 
When the patients were asked as to how often they came across situations whereby times for 
medication came when they were far from home; and if that did prevent them from taking their 
drugs, 71% indicated that they carried their pills with them every time.  17% reported taking 
their medication only at night, as such, not seeing the need to carry their ARV drugs when they 
left their respective homes; and the rest indicated that they made sure to take their pills before 
they left their residential places in the morning, and other doses would be taken in the evening 
when they were back home. In this 71% of patients who reported taking their pills with them, 
four were men and 13 were women, and two patients disclosed having problems at work in that, 
their workplaces were non-eating zones and that preventing them to take the pills when they 
were at work.  
 
4.2.4 Respondents attitude/perceptions towards ARV treatment 
All the patients (100%) had a positive attitude towards ARV drugs although some disclosed that 
at the initiation stage, they had absolutely no belief in ART. The pie chart below demonstrates 
distribution of the participants according to their belief in ART at the initiation stage. 
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Figure 4.5  
 
Figure 4.5 Distribution of the respondents according to their belief in ART 
Although seven respondents had no belief in ART at the beginning of the treatment, no patient 
reported stopping medication. Disbelief in the therapy came into being as a result of severely 
compromised immune system.  
One patient believed: 
“My health conditions at the initiation stage of the therapy had deteriorated so much that I 
doubted the potential for ARVs to reform my health and physical conditions, and sustain my 
life.” 
When the patients were confronted with the question of how ARVs as a life-long treatment 
affected their attitude towards the therapy, 88% reported having no problem with ART as a life-
long treatment. The remaining 12% found having to take tablets daily irritating.  
A respondent admitted: 
“Sometimes it feels unbelievable that my life hinges on these tablets, and their smell, especially 
in the morning, is disgusting.” 
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The common opinion among the respondents was that ARVs should be in the form of three to six 
months injection. None of these patients reported having stopped medication as a result.  
 
4.2.5 The influence of religion and other social aspects of life 
Almost all the patients (96%) did not find their religion as encumbering their medication intake. 
4% reported having trouble with the church at the beginning.  
The respondent disclosed: 
 “I encountered a big problem with the church leaders all because they recommended black tea 
given at the church as a substitute for ARVs.” 
 But for 100%, religion was not a factor. 12% found having to drop some of their social habits 
such as excessive drinking and smoking a huge challenge at the beginning, or during merry-
making times.  But all the patients (100%) could not let their social life affect adherence to ART.  
 
4.2.6 Factors emanating from provision of services at the hospital 
a) Provision of excellent service 
The majority of respondents reported receiving excellent services at the clinic. These included 
the manner in which the healthcare providers communicated with them while in the queues 
awaiting medication, the way they were given instructions on how to take medication and how 
motivating were the counseling processes. The bar chart below provides the statistics of patients 
who were satisfied and those who were not, concerning the services at the hospital. 
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Figure 4.6  
 
Figure 4.6 Distribution of participants according to their feelings concerning the services at 
the hospital. 
On average, 89% of the respondents were satisfied with the manner in which the health 
personnel treated them when they came to collect their medication, while 11% reported not 
receiving satisfying services from the healthcare practitioners. The four unhappy patients 
mentioned one or two incidences in which they did not receive fair treatment at the clinic. One 
patient even held the personnel responsible for his default. 
The patient stated: 
 “A rude provider made me feel disrespected and compelled never to set my foot at this clinic. 
While at home I sought remedy from traditional healers. My health conditions became worse and 
forced me to return. Since my return I never had any conflict with any physician, and I realize it 
was just a bad day for the poor provider.”  
The majority of respondents (92%) on average were ecstatic about the way instruction were 
given and counseling processes which were some kind of extrinsic motivation for adherence. 8% 
were not happy with the length of time counseling processes took at the initial stage of ART.  
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The patient indicated: 
“When I started ART, I was physically weak; my health conditions had deteriorated so badly. 
The counseling processes took me full two weeks. Sometimes I would come here and leave late in 
the afternoon, hungry and exhausted. Given my health conditions at that time, the processes 
were time-consuming and not fair to me at all.” 
b) Number of times to report and time spent at the clinic 
On being asked how many times they had to report at the hospital to collect their medications, 
the respondents provided different answers shown below. 
Figure 4.7  
 
Figure 4.7 Distribution of respondents according to number of times they had to report at 
the clinic. 
No patient reported having to report at the hospital a number of times in a month, and patients 
were happy with that. On being asked how much time they normally spent at the clinic when 
they had come for their treatment, the respondents mentioned times ranging from two –three 
hours, and they were satisfied with that. 
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4.2.7 Barriers, causes and reasons behind non-adherence found from qualitative research 
interviews with patient-participants 
Factors affecting adherence to ART found from the interview with the patients are summarized 
in the table below. 
Table 2 Summary of all the factors prevalent in the study population 
FACTORS FREQUENCY PERCENT 
Medication side effects 3 9.0 
Illness 2 6.0 
Forgetfulness 10 30.3 
Poverty 9 27.2 
Fear of stigma/disclosure 7 21.2 
Relocation 1 3.0 
Provider – patient 
relationships 
1 3.0 
 
Table 2 
 
4.3 HEALTHCARE PROVIDER-PARTICIPANTS 
In total, six health personnel who fulfilled inclusion criteria of 12 months of experience in 
HIV/AIDS field consented to participant in the study. The participants‟ number of years in the 
field ranged from two to six. The line of questions in this category was more inclined to establish 
the process of ART delivery to the patients.  
4.3.1 Patient loss to follow-up (LTFU)/Default cases 
In October 2011, 11 patients were deregistered from the hospital patients‟ registry, following 
their death as a result of defaulting from the treatment (October Report 2011-Leratong Hospital). 
On being asked about default cases in the clinic, all the provider-participants (100%) defined 
ART default rate as alarming and believed that it posed a serious threat in the management of 
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HIV/AIDS. The table below depicts the reasons behind the growing number of default cases 
provided by the respondents. 
Table 3 Depicting the reasons behind the escalating ART default rate 
REASONS BEHIND ART NON-
ADHERENCE/DEFAULT CASES 
FREQUENCY OR 
NUMBER OF 
PARTICIPANTS WHO 
MENTIONED IT 
PERCENT OF 
PARTICIPANTS 
MENTIONING THE 
CAUSE 
1. Medication specific reasons 
 Side effects   
 Taste of treatment   
 Size of tablets      
 Strict medication rules, e.g.  No 
smoking, drinking, etc.                    
 
6 
1 
1 
 
2 
 
100% 
17% 
17% 
 
33% 
2. Social and economic reasons 
 Poverty (unemployment, lack 
of/low income, no food). 
 Non-disclosure/stigma 
 Dependency  
 
6 
 
4 
2 
 
100% 
 
67% 
33% 
3. Patient related reasons 
 Relocation 
 Feeling/getting better 
 Lack of social support 
 Social aspects of life such as 
alcohol, smoking, etc. 
 Denial 
 Traditional medication 
 
1 
5 
3 
3 
 
2 
2 
 
17% 
83% 
50% 
50% 
 
33% 
33% 
4. Healthcare team & system reasons 
 No monitoring staff / staff 
shortages 
 
2 
 
33% 
 
Table 3 
All respondents (100%) found medication side effects and poverty as responsible for the growing 
number of defaulters at the clinic while relocation, taste of the treatment and size of the pills 
were mentioned by few participants. Four participants (67%) did not find any factors related to 
the healthcare team and system. In this 67%, one highlighted shortage of staff and that subjecting 
them to a lot of work, which compelled them to work over time. But in the final analysis, the 
respondent did not see that as contributing to patients defaulting from treatment as the 
respondent‟s closing statement was that they were managing. Two physicians (33%) reported 
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shortage of staff resulting in inefficiency, as such, failing the patients. One participant said that 
there was no adequate staff to do monitoring and that created gaps, which contributed to 
defaulting of the patients. 
With regard to the question of assisting patients to cope with medication side effects, 100% of 
the respondents mentioned ongoing counseling in which patients were informed about side 
effects, monitoring and finally change of medication in case side effects persisted. 
On being asked about the kind of mechanisms they employed to have their patients 
psychologically prepared for ART, all the participants (100%) mentioned that patients went 
through two counseling sessions prior to ART initiation. 67% saw these mechanisms working 
towards achieving the primary objective of raising the levels of adherence.  
The participant believed: 
“Our mechanisms are working because some patients really maintain high level of adherence.” 
However, 33% of the participants did not see the mechanisms employed by the staff as working. 
One of the respondents had it that: 
 “We cannot say they are working when there is this huge number of defaulters. These two 
counseling sessions before ART initiations are not enough. Four counseling sessions are 
necessary so that, when the patient starts the treatment, he/she has thorough knowledge and 
understanding of ARVs.” 
On being asked if their patients were honest about their reasons behind defaulting or non-
adhering to the treatment, 100% said that their patients were not honest at all. 
 
4.3.2 Availability/accessibility of ARV drugs at the clinic 
One hundred percent of the respondents indicated that they never experienced any shortages of 
drugs in the clinic. ART was always available and accessible. 
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4.3.3 ART delivery to the patients 
When the participants were asked to provide a detailed account on how the ART programme was 
delivered to the patients, similar points which were presented differently emerged from their 
responses. In a nutshell, the respondents reported that they received patients from local clinics 
with referral letters. 
The participant explained: 
“A patient is initiated with CD4 count of 350 according to the new protocol. A file for the patient 
is opened and then we stabilize the patient for treatment initiation: two counseling sessions 
commence in which we prepare our patients for possible side effects and explain to them that the 
treatment is a life-long thing. The patient is then sent to a social worker, from there to a 
dietician, then to ex-tray and then to a doctor. All these happen prior to ART initiation. When the 
patient has gone through all these processes, we know he/she is ready for ART. All these 
processes will take him/her two weeks after which we initiate our patient to the therapy.” 
“For patients whose health and physical conditions have deteriorated, all these processes may 
take a lot of time at the expense of health of the patients. Do you ignore the urgency of a need to 
give the patient medical attention all in the name of the processes that have to come prior to 
initiation?” 
“Some patients come here in critical conditions, with CD4 count that has dropped significantly- 
far below 100. In that case initiation is done instantly.” 
On being asked if they saw the programme delivery contributing to medication non-adherence, 
the majority (67%) said that the manner in which the programme was delivered to the patients 
had no contribution whatsoever to non-adherence. 33% had their reasons for saying it had some 
contribution. One said that there was no monitoring staff, and that caused default cases. Another 
one mentioned that the patients were put to the treatment after a short time when they had not 
fully understood ARVs. 
Concerning the question of how the defaulters were helped not to default for the second time, the 
respondents said that defaulters were called and initiated to six months adherence counseling 
sessions. 
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“The nature of the phenomenon of adherence tells that high levels of patience are necessary to 
deal with patients of this disease. How do you ensure that your staff has what it takes to deal with 
the patients in such a manner that they will be motivated to adhere?” 
“In-service training and refresher courses are done on regular basis to enable the staff to deal 
with patients with that required level of patience.” 
 
4.4 DISCUSSION OF FINDINGS 
From qualitative findings, distinct similar and dissimilar thematic units were identified and 
aggregated into the following themes: the relationship between gender and treatment 
compliance; medication specific factors, socio economic factors, patient-related factors and 
patients‟ relationship with healthcare providers. 
 
4.4.1 The relationship between gender and treatment compliance 
There was a higher number of female (62.5%) than males (37.5%) in the study. The reasons for 
this imbalance were a lower proportion of men attending the clinic, compared to women, and 
men‟s reluctance to participate in the study. This revealed that women in general are more open 
to discuss their health-related matters than men. One of the key findings in this study was that, 
on average, 54% of the respondents were adherent to medication, but the required adherence 
level of ≥95% was achieved only by 41% of the participants. There were four default cases in 
this study, of which 80% were men and 20% women. From 20%, the reason behind defaulting 
was severe sickness while those from 80% included among others unfair treatment. This shows 
adherence counseling did not have any significant impact in this regard.  
 
4.4.2 Medication specific factors 
ART medication regimens have severe side (adverse) effects and strict time requirements that 
presented a real challenge to adherence. 83% of patient-participants experienced physical 
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discomfort soon after ART initiation, of which two even decided to stop medication because of 
intolerable adverse effects when one was left with no option but to quit medication due to illness. 
Medication side effects was one of the most frequently reported contextual factors by both 
provider-participants. 100% mentioned side effects as highly influencing adherence among 
PLWHA. 
Strict time requirements subject the patients to a huge challenge. 71% of the respondents had a 
problem adhering to specified times for medication intake. The most frequently mentioned 
reason was forgetfulness. The findings in this study are similar to those in the study conducted 
by Mahlangu (2008) between July 2004 and August 2005 at the Dr George Mukhari Hospital in 
Pretoria, in which forgetting was the most common reason for missing doses, constituting 26.6% 
of all the reasons. These show the extent to which the above mentioned medication specific 
factors are a cause for concern in the management of HIV/AIDS. 
 
4.4.3 Socio economic factors 
Social and economic factors highly prevalent among the patients were poverty and stigma. From 
the majority of patient-participants, transportation costs and food shortages were the main factors 
hampering adherence to ART. Both provider and patient-participants reported poverty as 
rendering the patients failure to adhere to both dates scheduled for appointments and times 
specified for medication intake. 
Fear of stigma was one of the chief determinants of non-adherence. Fears to take medication in 
the public view forced the patients to skip their doses. In this study, stigma was linked to non-
disclosure in that patients concealed their status due to fear of being stigmatized. Fear of being 
divorced or abandoned by the partners compelled dependent women to remain silent about their 
HIV-status. Most people who reported having fears to disclose their HIV-status to their partners 
indicated that they were financially dependent on those partners and they could not risk it as 
disclosure might give birth to the end of marriage or cohabitation. Poverty was in a way 
exacerbating stigma. There is a growing recognition that social support is vital in fostering ART 
adherence. The findings revealed a significant relationship between non-adherence and poverty, 
stigma as well as non-disclosure, the latter denying the patients opportunity for social support. 
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4.4.4 Patient-related factors 
In this category, factors which were found to be a challenge to adherence included belief about 
efficacy of ARVs, ART as a life-long treatment, religious beliefs and social practices, as well as 
relocation. With reference to the issue of efficacy of the therapy, all the patients (100%) were 
aware of the need to take their ARV drugs as prescribed by physicians and they even approved 
ART for effective management of AIDS. The majority of the patients had no problem with ART 
as a life-long treatment. A few who had negative attitude toward ART as a life-long treatment 
had been on the therapy for a long time, so the thought of the pills and how they tasted initiated 
for them a bad feeling about the drugs. Those were patients who even suggested that the 
government should provide ARVs in the form of three to six months injection.  
All the patients did not see religious or traditional beliefs and social habits as factors that should 
hamper adherence. This revealed a thorough understanding the patients had of the importance of 
ART in the management of the disease, and the knowledge that traditional beliefs and medicines 
were more likely to waste their time and exacerbate their health conditions rather than helping 
them. But what the patients said was contrary to what their physicians divulged. Providers said 
that some patients had a tendency of substituting ARVs with traditional medicines, or denying 
being HIV positive on the grounds that they were being bewitched. 
 
4.4.5 Patients’ relationship with healthcare providers 
Harmonious relationships cultivated for a growth of trust in patients for their physician 
knowledge and expertise, and that was a key factor in patients adherence to dates scheduled for 
appointments. The majority of patients believed that health personnel were competent advocates 
of ART medication, who prescribed it with all patience and adequacy. A few patients who 
reported having been treated unfairly by the physicians also quoted a few instances in which 
unfair treatment was administered upon them, by one or two personnel. They believed that the 
majority of the personnel treated them with all patience, respect and nonjudgmental attitude and 
they were happy. This confirms Marelich et al (in Wekesa, 2007) thus: a great deal of adherence 
hinges on the positive interaction between patients and their health care providers. 
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Dealing with PLWHA on ART is straining work as a result of explaining one thing or dealing 
with the same people several times. It requires a lot of patience as other patients default while 
others grow hostile. The complexities of ART treatment which require patients to be involved in 
their treatment decisions, and the fact that patients need to be adequately informed about their 
treatment schedules and the importance of adhering to treatment regimen (Wekesa, 2007), 
combined with all the reported processes followed before ART initiation, require a high level of 
patience from the side of the health personnel. The in-service training that the health 
practitioners reported to be regularly attending was working if in the end, 89% of the patient-
participants were happy with service delivery at Kgothalang clinic. 
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CHAPTER 5: CONCLUSION AND RECOMMENDATIONS 
5.1 CONCLUSION 
The study set out to investigate the causes of non-adherence to ART medication regimens among 
PLWHA at Leratong hospital. The sampled population of patients (24) was very small to be 
representative of hundreds of people attending the clinic for ARVs, and to give a true reflection 
of adherence problems. So, the population was complemented with six healthcare providers 
whose knowledge of daily ART-related problems and experience of attending to hundreds of the 
clinic ART attendees gave the real picture concerning factors that affected adherence among the 
patients on HIV treatment. 
The study findings demonstrated that the research question and objectives had been met. 
Concluding from the sample that was used in this study, adherence levels among patients was not 
satisfactory. The findings indicated that the majority of PLWHA did not meet the required 
adherence level of ≥ 95%. Generally, adherence level among the patients was sub optimal (less 
than 95%). Social economic related factors such as poverty (transportation costs and insufficient 
food), stigma and fear of disclosure; and medication side effects significantly contributed to non-
adherence. Patient-related factors such as lack of social support, preference of traditional 
medicines, feeling better, substance abuse; and one health system-related factor being staff 
shortages, had a little contribution to poor medication adherence. 
The process of ART delivery to the patients was intended to provide extrinsic motivation to the 
patients and raise adherence levels. The sequential steps followed in the process were 
stabilization of the patients, preparing the patients for ART and its possible concomitant side 
effects through counseling sessions in which the patients were adequately informed about ART 
as a life-long treatment and the importance of adhering to treatment, after which the patients 
would pass through a social worker, dietician and doctor. From there ART initiation followed. 
The process lasted two weeks. The newly initiated and non-compliant patients reported to the 
hospital every month, when the compliant patients with a relatively long time on ART reported 
once in two or three months. Defaulters were initiated to six month counseling sessions in order 
to minimize the chances of the same patients defaulting again. 
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The processes executed prior to ART initiation had potentially facilitated adherence, as they 
were meant to equip the patients with knowledge of ART. On the contrary, there was possibility 
of some patients finding them time-consuming and stopping the treatment even before it was 
commenced; the main determinants possibly being transportation costs, lack of food and feeling 
physically weak to come to the clinic when no medication was given. The minimum of a month 
for the patients to report at the hospital for their ARV drugs was enough for effective monitoring 
of the patients and treatment. It also saved the patients the trouble to incur more expenses 
through transport and food, and the patient-participants were very happy about it. 
The patients‟ view of the programme was that, the programme itself was a challenge to the 
patients in terms of its dos and don‟ts that patients usually fail to adhere to due to forgetfulness. 
Their suggestion directed not to the health centers, but to the government and all stakeholders 
including the ARV drugs-manufacturers, was that ART be provided in the form of three to six 
months injection, and that would give birth to relatively low levels of non-adherence if not zero.  
From the view of the majority of the personnel, the programme was fine and not contributing in 
any significant manner to non-adherence. A few who had a problem with the programme 
indicated its contribution to non-adherence emanating from a small number of counseling 
sessions that the patients passed through before ART initiation, which failed to equip them with 
thorough knowledge of ART programme. Another concern was inadequate staff in health 
facilities that delivered the programme to the patients. The personnel indicated that it gave birth 
to inefficiency in the delivery of the programme, as such, failing the patients who in the end did 
not adhere to ARV drugs. 
According to the health personnel, during immune reconstitution, the drugs picked out 
opportunistic infections which were still concealed, and the possibility was that the patient would 
feel seriously ill, and that was when the patient needed more attention, failing which non-
adherence would follow. So, in the situation where there was no adequate staff, there would be 
no monitoring and in the absence of proper monitoring, patients would quit medication. 
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5.2 RECOMMENDATIONS 
The participants stated a range of reasons behind non-adherence to ART medication regimens, of 
which poverty (insufficient food and transportation costs), stigma and fear of disclosure were a 
big threat to adherence. To enhance adherence to HIV treatment, the study recommends the 
Department of Health in Gauteng province and all other stakeholders to: 
 Look at ways to improve adherence in the face of poverty, by way of ensuring a greater 
interaction between the social development and Health components of government in 
relation to HIV. 
 
 Eradicate stigmatization of PLWHA by way of intensifying health education campaigns 
against stigma in communities, workplaces and households. 
 
 Develop a binding policy for the managers and employers, which will allow our patients 
on ART to take their bottles of water into “Non-eating zone” workplaces in order to take 
their pills when time for medication intake has come. 
 
 Evaluate and reinforce mechanisms for monitoring of patients on ART by way of 
ensuring the presence of adequate staff in health facilities. 
The study revealed that forgetfulness is profoundly influencing adherence among the patients. 
So, it is recommended that patients: 
 Be encouraged and supported to have an effective family and social support system that 
will assist in ensuring that they always carry their drugs with them, and take them when 
the time has come. 
 
 Be encouraged to choose the time that is convenient for them and the adherence family 
support system should be knowledgeable of that time. 
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The findings from this study show that there is a significant relationship between treatment 
adherence and gender, in which women are generally more compliant than men to ART, so it is 
recommended that men be given extra pre-ARV counseling and compliance checking. 
The findings further show that, the more time people have on ART, the less adherent they are 
likely to become. There is a need for more compliance checking as treatment goes on. 
 
5.3 SUGGESTION FOR FURTHER RESEARCH 
(a) There is a need for a similar study with similar objectives to be conducted in resource- 
poor settings/ rural areas whose sample population will be bigger than the one used in 
this study, to determine adherence situation in the province/country. 
 
(b) This study did not examine if age has any relationship with adherence, so further research 
should also look into that. 
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